Healthcare -
Biotechnology - NASDAQ - US
$ 0.6773
5.8 %
$ 61.3 M
Market Cap
-0.37
P/E
Price Target
Average
1730.80%
Revenue Forecast
Estimate
170.16%
EBIT
Estimate
32.52%
Net Income
Estimate
81.08%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verrica Pharmaceuticals Inc.
Wall Street analysts predict an average 1-year price target for VRCA of $12.4 , with forecasts ranging from
a
low of
$10 to a high of $14 .
VRCA Lowest Price Target
Wall Street Target
10 USD
1376.45%
VRCA Average Price Target
Wall Street Target
12.4 USD
1730.80%
VRCA Highest Price Target
Wall Street Target
14 USD
1967.03%
REVENUE FORECAST
Revenue Forecast Chart VRCA
EBIT FORECAST
EBIT Forecast Chart VRCA
NET INCOME FORECAST
Net Income Chart VRCA